Nurix Therapeutics Employee Directory
Biotechnology ResearchCalifornia, United States201-500 Employees
Nurix Therapeutics is a mid-sized biotechnology company based in Brisbane, California, focused on the discovery, development, and commercialization of targeted protein degradation medicines. The company aims to transform disease treatment by exploiting the cell’s ubiquitin-proteasome system to remove disease-causing proteins, seeking options that address limitations of existing therapies. It describes itself as a clinical-stage biopharmaceutical company, actively advancing degraders through development. This approach places Nurix within the biotechnology research sector, pursuing a methodology that centers on protein degradation. Its work targets areas including malignant hematology, immunology, and neurology, supported by strategic collaborations such as a global Roche partnership to co-develop and co-commercialise a BTK degrader, bexobrutideg. In 2026, Nurix announced bexobrutideg-related presentations at scientific meetings, reflecting ongoing clinical development.
1-888-653-2347 
support@leadiq.com 
